Akihiro Kamikawa

Dr. Akihiro Kamikawa

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2009 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
AKAkihiro Kamikawa
Akihiro Kamikawa
OIOsamu Ichii
Osamu Ichii
DYDaisuke Yamaji
Daisuke Yamaji
TITakeshi Imao
Takeshi Imao
CSChiharu Suzuki
Chiharu Suzuki
KKKazuhiro Kimura
Kazuhiro Kimura
Mammary glands develop postnatally in response to the hypothalamic‐pituitary‐gonadal axis. Obesity‐induced changes in the local environment, however, retard mammary gland development during late pregnancy and lactation. To clarify the effects of obesity on fundamental duct development, we compared the mammary glands of nulliparous nonpregnant obese mice fed a high‐fat diet with those of lean mice fed a normal diet. Obese mice had enlarged mammary glands, reflecting fat pad size, whereas the ducts in obese mice showed a less dense distribution with less frequent branching. Additionally, the ducts were surrounded by thick collagen layers, and were incompletely lined with myoepithelium. Because leptin receptors were localized in the epithelium region and leptin that was highly expressed in the obese glands suppressed mammary epithelial cell proliferation in vitro, the present results suggest that obesity disrupts mammary ductal development, possibly by remodeling the mammary microenvironment and promoting the expression of such paracrine factors as leptin. Developmental Dynamics 238:1092–1099, 2009.

19 December 2007 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
AKAkihiro Kamikawa
Akihiro Kamikawa
TITatsuya Ishii
Tatsuya Ishii
KSKohei Shimada
Kohei Shimada
KMKennedy Makondo
Kennedy Makondo
OIOsamu Inanami
Osamu Inanami
KKKazuhiro Kimura
Kazuhiro Kimura

16 July 2016 in Cells Tissues Organs
Verified
Journal Article
Closed access
DKDaisuke Kondoh
Daisuke Kondoh
AKAkihiro Kamikawa
Akihiro Kamikawa
MSMotoki Sasaki
Motoki Sasaki
NKNobuo Kitamura
Nobuo Kitamura
Glycoconjugates in the olfactory system play critical roles in neuronal formation, and α1-2 fucose (α1-2Fuc) glycan mediates neurite outgrowth and synaptic plasticity. Histochemical findings of α1-2Fuc glycan in the mouse olfactory system detected using Ulex europaeus agglutinin-I (UEA-I) vary. This study histochemically assessed the main olfactory and vomeronasal pathways in male and female ICR and C57BL/6J mice aged 3-4 months using UEA-I. Ulex europaeus agglutinin-I reacted with most receptor cells arranged mainly at the basal region of the olfactory epithelium. The olfactory nerve layer and glomerular layer of the main olfactory bulb were speckled with positive UEA-I staining, and positive fibers were scattered from the glomerular to the internal plexiform layer. The lateral olfactory tract and rostral migratory stream were also positive for UEA-I. We identified superficial short-axon cells, interneurons of the external plexiform layer, external, middle and internal tufted cells, mitral cells and granule cells as the origins of the UEA-I-positive fibers in the main olfactory bulb. The anterior olfactory nucleus, anterior piriform cortex and olfactory tubercle were negative for UEA-I. Most receptor cells in the vomeronasal epithelium and most glomeruli of the accessory olfactory bulb were positive for UEA-I. Our findings indicated that α1-2Fuc glycan is located within the primary and secondary, but not the ternary, pathways of the main olfactory system, in local circuits of the main olfactory bulb and within the primary, but not secondary, pathway of the vomeronasal system.

1 March 2010 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
LNLina Nordquist
Lina Nordquist
KSKohei Shimada
Kohei Shimada
TITatsuya Ishii
Tatsuya Ishii
DFDaniela Tomie Furuya
Daniela Tomie Furuya
AKAkihiro Kamikawa
Akihiro Kamikawa
KKKazuhiro Kimura
Kazuhiro Kimura

29 September 2009 in Journal of Dairy Research
Verified
Journal Article
Closed access
PDF file
MEMabrouk Abd eldaim
Mabrouk Abd eldaim
AKAkihiro Kamikawa
Akihiro Kamikawa
Mohamed Mohamed SolimanMohamed Mohamed Soliman
Mohamed Mohamed Soliman
MAMohamed AHMED
Mohamed AHMED
YOYuko Okamatsu-Ogura
Yuko Okamatsu-Ogura
KKKazuhiro Kimura
Kazuhiro Kimura
Retinol-binding protein 4 (RBP4) is a plasma protein involved in retinol transportation, and recent evidence in rodents suggests that RBP4 is also a metabolic regulator that modifies insulin sensitivity. To assess how RBP4 levels are regulated in ruminants, we determined the RBP4 concentrations in bovine plasma and milk using Western blot analysis. Plasma RBP4 levels in non-pregnant non-lactating (control) cows were around 45 μg/ml, which were sustained during 60-h fasting, but decreased significantly 4 h after lipopolysaccharide (LPS) administration. Basal plasma retinol concentration was around 30 μg/dl, but this decreased to approximately one-third and one-half of these values during fasting and 8 h after LPS challenge, respectively. Plasma RBP4 and retinol levels in cows 3–6 d before parturition were comparable to those of the controls. However, on the day of parturition both were significantly decreased and had returned to basal levels by two weeks after calving. Interestingly, RBP4 was clearly detected in colostrum (16·4±5·6 μg/ml) but was only faintly detected in milk from cows at 7 d and 15 d after calving. Retinol concentrations in colostrum were almost 10-fold higher than those in plasma, while those in milk were comparable to those in plasma. These results suggest that RBP4 and retinol levels are independently regulated under physiological and pathophysiological conditions and that RBP4, like retinol, is transferred from maternal stores to calves through colostrum.

18 February 2010 in Lupus
Verified
Journal Article
Closed access
PDF file
OIOsamu Ichii
Osamu Ichii
AKAkihiro Kamikawa
Akihiro Kamikawa
SOS. Otsuka
S. Otsuka
YHY. Hashimoto
Y. Hashimoto
NSN. Sasaki
N. Sasaki
YKY. Kon
Y. Kon
B6.MRLc1(82—100) congenic mice carrying the telomeric region of lupus-prone MRL chromosome 1 develop autoimmune glomerulonephritis (GN). The GN susceptibility locus of B6.MRLc1(82—100) contains the interferon activated gene 200 (Ifi200) family, which consists of Ifi202, 203, 204, and 205. Recently, Ifi202 was suggested as a candidate gene for murine lupus. In this study, we assessed the association between Ifi200 family and GN in several disease models. We compared the expression of Ifi200 family members in 24 organs between the C57BL/6 and B6.MRLc1(82-100). The expressions of Ifi200 family members differed between strains, and the most dramatic differences appeared in Ifi202 expression. Briefly, in the blood, immune organs, lungs, and testes mRNA expression was higher in B6.MRLc1(82—100) mice. In the kidney and immune organs, only Ifi202 expression increased with the development of GN in B6.MRLc1(82—100), and significant differences from C57BL/6 were observed even before disease onset. Ifi202 expression in the kidneys of BXSB, NZB/WF1, and MRL/lpr was also significantly high in the early- and late-disease stages. Furthermore, laser microdissection-reverse-transcriptase-polymerase chain reaction analysis confirmed the high Ifi202 expression in all areas of B6.MRLc1(82—100) kidneys. In conclusion, in the Ifi200 family, Ifi202 expressions in the kidney and immune organs significantly increased with GN progression.